Skip to main content
. 2018 Feb 12;2018(2):CD004121. doi: 10.1002/14651858.CD004121.pub4
Study Reason for exclusion
Ferrandina 2003 Laboratory study of celecoxib in cervical cancer cell lines
Herrera 2007 Phase I‐II study of celecoxib with chemoradiation in patients with cervical cancer
Mitchell 1995 Review of chemoprevention trials and surrogate end point biomarkers in the cervix
Vlastos 2003 Review of biomarkers and their use in cervical cancer chemoprevention